FSB Premier Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$418K Sell
1,920
-27
-1% -$5.99K 0.13% 151
2025
Q4
$445K Buy
1,947
+14
+0.7% +$3.19K 0.14% 146
2025
Q3
$448K Buy
1,933
+5
+0.3% +$1.02K 0.15% 144
2025
Q2
$358K Sell
1,928
-243
-11% -$45.2K 0.13% 157
2025
Q1
$455K Buy
2,171
+285
+15% +$55.4K 0.18% 129
2024
Q4
$335K Hold
1,886
0.13% 155
2024
Q3
$372K Buy
1,886
+116
+7% +$21.6K 0.15% 145
2024
Q2
$304K Buy
1,770
+5
+0.3% +$828 0.14% 144
2024
Q1
$321K Buy
1,765
+5
+0.3% +$862 0.15% 133
2023
Q4
$273K Buy
1,760
+4
+0.2% +$583 0.14% 137
2023
Q3
$262K Buy
1,756
+5
+0.3% +$734 0.15% 126
2023
Q2
$236K Buy
1,751
+8
+0.5% +$1.17K 0.13% 135
2023
Q1
$278K Buy
1,743
+62
+4% +$9.48K 0.15% 116
2022
Q4
$272K Buy
1,681
+4
+0.2% +$613 0.15% 120
2022
Q3
$225K Buy
1,677
+3
+0.2% +$430 0.13% 124
2022
Q2
$256K Sell
1,674
-136
-8% -$20.8K 0.14% 121
2022
Q1
$283K Buy
1,810
+35
+2% +$5.08K 0.14% 114
2021
Q4
$240K Buy
+1,775
New +$210K 0.1% 118
2021
Q3
Sell
-1,997
Closed -$225K 105
2021
Q2
$225K Buy
1,997
+4
+0.2% +$450 0.12% 95
2021
Q1
$215K Sell
1,993
-614
-24% -$65.7K 0.12% 93
2020
Q4
$279K Buy
+2,607
New +$251K 0.15% 86

Other funds holding ABBV

FSB Premier Wealth Management's ABBV Position: Q1 2026 in Review

FSB Premier Wealth Management reduced its AbbVie (ABBV) stake by 1.4% in Q1 2026, selling an estimated $5.99K and leaving 1,920 shares worth $418K. The position accounts for 0.13% of the portfolio, ranked #151.

FSB Premier Wealth Management first reported a position in ABBV in Q4 2020 and has held it in 21 quarters since. The position peaked at $455K in Q1 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • FSB Premier Wealth Management held 1,920 shares of AbbVie worth $418K as of Q1 2026.
  • FSB Premier Wealth Management sold 27 AbbVie shares in Q1 2026, an estimated $5.99K.
  • AbbVie made up 0.13% of FSB Premier Wealth Management's portfolio in Q1 2026, its #151 holding.
  • FSB Premier Wealth Management first reported a position in AbbVie in Q4 2020 and has held it in 21 quarters since.
  • FSB Premier Wealth Management's AbbVie position peaked at $455K in Q1 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on FSB Premier Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.